Results 61 to 70 of about 809,443 (296)

Time-study research on maxillofacial prosthetic treatment

Japanese Dental Science Review
Unreasonable medical fees can cause problems such as increased medical costs, greater medical disparities, decreased medical standards, and physician shortages.
Mai Murase, Haruka Fujita, Meiko Oki, Fumi Yoshioka, Yuichiro Nishiyama, Tetsuo Ohyama, Chihaya Matsumoto, Satomi Usui, Yuji Sato, Tadashi Sado, Hidekazu Takahashi, Keiichi Sasaki, Miwa Matsuyama, Yuka Sumita   +13 more
doaj   +1 more source

User fees in private non-for-profit hospitals in Uganda: a survey and intervention for equity

International Journal for Equity in Health, 2005
Background In developing countries, user fees may represent an important source of revenues for private-non-for-profit hospitals, but they may also affect access, use and equity.
Maciocco Gavino, Macaluso Anna, Kweyatulira Annet, Cattaneo Adriano, Asio Salome, Amone Joseph, Mukokoma Maurice, Ronfani Luca, Santini Stefano   +8 more
doaj   +1 more source

Cost-sharing in the Greek Health Centres: The Administrative Personnel Aspects [PDF]

, 2013
Cost-sharing was introduced in Greece to supplement the state finance and social insurance funds and make patients cost-conscious. A questionnaire was distributed to 193 administrative personnel (response rate 96 per cent).
Chondrocoukis, G. P., Stokou, E. G., Vozikis, A.   +2 more
core  

DRGs in Transfusion Medicine and Hemotherapy in Germany [PDF]

, 2012
Patients requiring transfusion medicine and hemotherapy in an inpatient setting are incorporated into the German Diagnosis Related Groups (G-DRG) system in multiple ways.
Bauer, Matthäus, Ostermann, Helmut
core   +2 more sources

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock, Jin Nakahara, Becky Parks, Kerstin Allen, Sami Fam   +4 more
wiley   +1 more source

Australian general practice registrars’ billing patterns: a cross-sectional analysis from the Registrars Clinical Encounters in Training (ReCEnT) study

BMC Health Services Research
Background In Australia, a government insurance scheme (Medicare) pays set rebates for a range of distinct general practitioner (GP) services. GPs may ‘bulk-bill’ and accept the Medicare rebate fee directly, or ‘privately-bill’ by charging the patient a ...
Katie Fisher, Amanda Tapley, Anna Ralston, Andrew Davey, Elizabeth Holliday, Jason Dizon, Susan Wearne, Alison Fielding, Mieke van Driel, Neil Spike, Lisa Clarke, Parker Magin   +11 more
doaj   +1 more source

Like Disney For Adults: Life In Freedom Village [PDF]

, 2016
With an increasingly aging population, American society needs to more effectively address living options for the aging population in the present and future. Older adults have unique needs due to their age, physical and mental condition, varying needs for
Schuster, Janice G.
core   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Path analysis of factors influencing length of stay and hospitalisation expenses for oral cancer patients in tertiary hospitals in southeastern China: a cross-sectional study

BMJ Open
Aims To investigate the associations between influencing factors with length of stay (LOS) and hospitalisation expenses in oral cancer (OC) patients, and to explore the potential pathways through which these factors influence hospitalisation expenses ...
Jing Wang, Chen Chen, Xiaoying Hu, Yi Fan, Yaping Wang, Yu Qiu, Qiujiao Yang, Mingming Xu, Yanfeng Weng, Yanni Li, Lisong Lin, Fa Chen, Baochang He, Fengqiong Liu   +13 more
doaj   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Mert Sisman, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier   +9 more
wiley   +1 more source